As a result of the entry into force of Regulation (EU) 2019/677 of 29th April 2019 concerning the non-renewal of chlorothalonil approval, ANSES withdraw 25 authorisations […]
In Anses Opinion dated 19 April 2019, Anses concluded that Epoxiconazole is an endocrine disruptor for humans and non-target organisms. Further to this evaluation, Anses has […]
As a result of the entry into force of Regulation (EU) 2018/1865 of 28th November 2018 concerning the non-renewal of propiconazole approval, ANSES has withdrawn 23 […]
As a result of the entry into force of Regulation (EU) 2018/1914 of 6th December 2018 concerning the non-renewal of quinoxyfen approval, ANSES has withdrawn 5 […]